World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: REBEC
Last refreshed on: 27 May 2013
Main ID:  RBR-58yq52
Date of registration: 16/04/2012
Primary sponsor: Departamento de Clinica Médica, Faculdade de Ciências Médicas, Universidade Estadual de Campinas - UNICAMP - Campinas, SP, Brazil
Public title: Acupuncture in Multiple Sclerosis
Scientific title: Impact of electroacupuncture on quality of life for patients with Relapsing-Remitting Multiple Sclerosis under treatment with immunomodulators
Date of first enrolment: 01/01/2011
Target sample size: 31
Recruitment status: data analysis completed
URL:  http://www.ensaiosclinicos.gov.br/rg/RBR-58yq52/
Study type:  Intervention
Study design:  Randomized, parallel, single blinded with two arms clinical trial.  
Countries of recruitment
Brazil
Contacts
Name: Juan  Quispe-Cabanillas
Address:  Lab.Neuroimunologia, Departamento de Genética, Evolução e Bioagentes do Instituto de Biologia da Unicamp 13083-970 Campinas Brazil
Telephone: (19)35216263
Email: juangqc@fcm.unicamp.br
Affiliation:  Departamento de Clinica Médica, Faculdade de Ciências Médicas, Universidade Estadual de Campinas - UNICAMP
Name: Juan  Quispe-Cabanillas
Address:  Lab.Neuroimunologia, Departamento de Genética, Evolução e Bioagentes do Instituto de Biologia da Unicamp 13083-970 Campinas Brazil
Telephone: (19)35216263
Email: juangqc@fcm.unicamp.br
Affiliation:  Departamento de Clinica Médica, Faculdade de Ciências Médicas, Universidade Estadual de Campinas - UNICAMP
Key inclusion & exclusion criteria
Inclusion criteria: Patients with a confirmed diagnosis of RRMS according to the revised 2005 McDonald criteria and under treatment with immunomodulatory drugs (interferon-beta and glatiramer acetate) were selected.
Exclusion criteria: Those individuals who had previously received acupuncture treatment were excluded.

Age minimum: 18
Age maximum: 0
Gender: -
Health Condition(s) or Problem(s) studied
Quality of life in Relapsing-Remitting Multiple Sclerosis
G35
I01.800
Intervention(s)
the study had two groups:
1.eletroacupuncture true (n=16)
2.eletroacupuncture sham (n=15).

The protocol consisted of 30 minutes of acupuncture (either true or sham electroacupuncture) once a week for six consecutive months.
Primary Outcome(s)
Clinical status, especially mobility, was assessed prior to the treatment, as well as after six months, using the Expanded Disability Status Scale (EDSS). Quality of life was also assessed prior to the initiation of treatment, as well as after three and six months; It was measured by the Functional Assessment of Multiple Sclerosis (FAMS) instrument, validated for Portuguese as (DEFU). Briefly, this is self-report questionnaire investigating patient perception of the quality of their lives, The six sub-scales assess mobility, symptoms, emotional well being/depression, general contentment, thinking/fatigue, and family/social well being, using a 5-point Likert-type scale ranging from “not at all” to “very much”, which yields a score between 0 (for not at all) and 4 (for very much) for each of the items. Pain was evaluated using the 10-point Visual Analogue Scale (VAS), 0= Worst possible pain and 10= No pain, applied just before the FAMS.
Secondary Outcome(s)
Occasionally, patients reported improvement in spasticity, sleep and bowel function.
Secondary ID(s)
0775.0.146.000-08
976/2008
Source(s) of Monetary Support
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) - Brasilia, DF, Brazil
Secondary Sponsor(s)
Alfredo Damasceno - Campinas, SP, Brazil
Benito Damasceno - Campinas, SP, Brazil
Carlos O Brandão - Campinas, SP, Brazil
Felipe von Glehn - Campinas, SP, Brazil
Juan G. Quispe-Cabanillas - Campinas, SP, Brazil
Leonilda M B Santos - Campinas, SP, Brazil
Wanderley D Silveira - Campinas, SP, Brazil
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history